TLDR A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.
A blinded clinical trial involving 20 subjects (4 female, 16 male) over 9 months demonstrated the effectiveness of Tomorrowlabs HIF strengthening factor [HSF] hair restoration technology in treating androgenic alopecia (AGA). The daily application of [HSF] resulted in improvements in hair thickness (+7.2%), hair density (+14.3%), and shine and elasticity (+20.3%). Hair loss was reduced by an average of 66.8% in responsive subjects after 6 months, and hair growth increased up to 32.5%, with an average change of 8.4% in all participants and 10.8% in responsive patients after 9 months. The hair growth cycle was also harmonized, with an average increase of +8.0% in anagen (growth phase) hair and a reduction of -14.0% in telogen (resting phase) hair. The product was found to be safe, beneficial for scalp health, and free of side effects.View this study on mdpi.com →
HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.
The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.
Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.
Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.
Minoxidil reduces lysine hydroxylase in skin cells.
Minoxidil slows fibroblast growth and collagen production, potentially treating keloids, hypertrophic scars, and connective tissue disorders.
Minoxidil slows down skin cell growth and may help treat scars and skin conditions.
Using minoxidil and tofacitinib together can effectively treat severe hair loss.